Abeona Therapeutics Inc.
ABEO
$4.95
$0.275.77%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 3.50M | 3.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 0.00 | 3.50M | 3.50M |
| Cost of Revenue | 41.22M | 38.26M | 38.15M | 39.72M | 40.55M |
| Gross Profit | -41.22M | -38.26M | -38.15M | -36.22M | -37.05M |
| SG&A Expenses | 29.85M | 28.00M | 25.76M | 22.13M | 19.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.21M | 60.75M | 56.74M | 53.99M | 51.70M |
| Operating Income | -64.21M | -60.75M | -56.74M | -50.49M | -48.20M |
| Income Before Tax | -63.73M | -71.03M | -52.60M | -76.66M | -54.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.73 | -71.03 | -52.60 | -76.66 | -54.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.73M | -71.03M | -52.60M | -76.66M | -54.19M |
| EBIT | -64.21M | -60.75M | -56.74M | -50.49M | -48.20M |
| EBITDA | -62.21M | -58.79M | -54.75M | -48.37M | -45.91M |
| EPS Basic | -1.79 | -2.25 | -2.09 | -3.20 | -2.59 |
| Normalized Basic EPS | -1.12 | -1.40 | -1.31 | -2.04 | -1.65 |
| EPS Diluted | -2.24 | -2.69 | -2.54 | -3.20 | -2.59 |
| Normalized Diluted EPS | -1.14 | -1.43 | -1.33 | -2.04 | -1.65 |
| Average Basic Shares Outstanding | 164.09M | 141.10M | 117.82M | 95.83M | 85.41M |
| Average Diluted Shares Outstanding | 175.30M | 152.32M | 129.03M | 95.83M | 85.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
